These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11523074)

  • 21. Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account.
    Ingel K; Jahn-Eimermacher A
    Biom J; 2014 Jul; 56(4):631-48. PubMed ID: 24817598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A variational approach to optimal two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Bayesian group sequential design for a multiple arm randomized clinical trial.
    Rosner GL; Berry DA
    Stat Med; 1995 Feb; 14(4):381-94. PubMed ID: 7746978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size determination in group-sequential clinical trials with two co-primary endpoints.
    Asakura K; Hamasaki T; Sugimoto T; Hayashi K; Evans SR; Sozu T
    Stat Med; 2014 Jul; 33(17):2897-913. PubMed ID: 24676799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blinded sample size recalculation in clinical trials incorporating historical data.
    Hees K; Kieser M
    Contemp Clin Trials; 2017 Dec; 63():2-7. PubMed ID: 28735110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional power and predictive power based on right censored data with supplementary auxiliary information.
    Sun L; Wan Y
    Stat Med; 2018 Aug; 37(18):2690-2699. PubMed ID: 29682770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
    Herrmann C; Pilz M; Kieser M; Rauch G
    Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internal pilots for observational studies.
    Gurka MJ; Coffey CS; Gurka KK
    Biom J; 2010 Oct; 52(5):590-603. PubMed ID: 20857422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I error in sample size re-estimations based on observed treatment difference.
    Shun Z; Yuan W; Brady WE; Hsu H
    Stat Med; 2001 Feb; 20(4):497-513. PubMed ID: 11223896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size computations for PK/PD population models.
    Kang D; Schwartz JB; Verotta D
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):685-701. PubMed ID: 16284914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connections between permutation and t-tests: relevance to adaptive methods.
    Proschan M; Glimm E; Posch M
    Stat Med; 2014 Nov; 33(27):4734-42. PubMed ID: 25156155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Internal pilot design for balanced repeated measures.
    Zhang X; Muller KE; Goodenow MM; Chi YY
    Stat Med; 2018 Feb; 37(3):375-389. PubMed ID: 29164637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional power calculations for clinical trials with historical controls.
    Korn EL; Freidlin B
    Stat Med; 2006 Sep; 25(17):2922-31. PubMed ID: 16479548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internal pilot studies for estimating sample size.
    Birkett MA; Day SJ
    Stat Med; 1994 Dec 15-30; 13(23-24):2455-63. PubMed ID: 7701146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs.
    Herrmann C; Rauch G
    Methods Inf Med; 2021 May; 60(1-02):1-8. PubMed ID: 33648007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.